Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sitagliptin (januvia) (1 trial)
Insulin Resistance (Phase 2)
Metabolic Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)